Boji Medical Technology Reports Significant Profit Growth Amid Operational Improvements

Boji Medical Technology Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting notable shifts in its technical metrics. The company has reported a significant growth in net profit, achieving an impressive 322.01% increase for the quarter ending September 2025. This marks a turnaround after two consecutive quarters of negative results, showcasing the company's resilience. In terms of operational efficiency, Boji Medical Technology has recorded its highest operating cash flow at CNY 52.72 million, alongside a net profit of CNY 17.19 million for the half-year period. The inventory turnover ratio has also reached a peak of 2.43 times, indicating effective inventory management. Despite these positive indicators, the company’s return on equity stands at 0.76%, and it is characterized by a relatively high price-to-book value of 3.83. Over the past year, the stock has generated a return of 29.54%, although profits have experienced a decline of 83.4%. The current dividend yield is noted at 0.1, reflecting the company's commitment to shareholder returns. For more insights on Boji Medical Technology Co., Ltd., including the latest Mojo Score and financial trend performance, visit: Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.